Clin2
NCT05759676Possibly a fitRecruiting

Diabetes and a new drug-free heart stent after angioplasty

Diabetes MellitusCoronary Artery Disease

Part of Heart & circulation, Hormones & metabolism clinical trials.

This trial tests whether a polymer-free amphilimus-eluting stent is safe and works well for people with diabetes after a recent heart blockage procedure. It may help improve how well the artery stays open, while tracking side effects over time.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,800 people
Ages
19 years and older
Study type
Observational

Who can take part

  • Be age 19 or older
  • Have had a heart artery opening procedure (coronary angioplasty) in the last month
  • Your stent used for the procedure must be Cre8™ or Cre8™ EVO
  • You must be able to take medicines used to prevent clotting (like aspirin and clopidogrel) and not have serious allergy to them or the stent materials/contrast dye
  • Not be pregnant, breastfeeding, or planning pregnancy during the study
  • Not plan to stop anti-platelet (blood clot prevention) medicines within the next 12 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06086496Enrolling by invitation
Study of a new drug-releasing stent for heart arteries

This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.

Seoul, Seoul
NCT01788592Recruiting
Study of drug-coated stents in routine heart procedure care

This study follows people who need a heart procedure to open narrowed coronary arteries using a drug-coated stent. It aims to see how well these stents work and how people do in everyday clinical practice.

Seoul
NCT05427786Recruiting· Phase 4
Heart medication during stent placement to improve blood flow

This study tests whether giving a drug called nicorandil directly into the heart artery just before placing a stent can help keep blood flow normal and reduce complications after the procedure.

Seoul
NCT07098195Not yet recruiting
A new drug-releasing stent for coronary artery disease

This trial is testing a new type of stent (a small tube that props open a narrowed heart artery) coated with a medicine called everolimus to keep the artery open. The study wants to see if the stent is safe and works well for people with coronary artery disease, which is narrowing of the heart's blood vessels.

NCT06300268Not yet recruiting
Stent study for blocked heart arteries

This trial tests a new stent (a small mesh tube) to open narrowed heart arteries and improve blood flow. It may help people with multiple blocked arteries who are having a procedure to widen them.

NCT07563231Not yet recruiting
Real-world safety and outcomes of a new heart stent

This study looks at patients who received a special type of heart stent (a small mesh tube that holds open a blocked artery) during a procedure called angioplasty at Geneva University Hospitals. The goal is to see how safe and effective this stent is in everyday practice.

Geneva

Hear when a new Diabetes Mellitus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.